Clinical Trials Browser

Not yet recruiting × OTHER × Lymphoma × Clear all

NCT07513129 2026-04-13

A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And Lymphomas

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Phase EARLY_PHASE1 Not yet recruiting

LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT07014293 2026-03-31

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Phase NA Not yet recruiting

Lymphoma

NCT07502872 2026-03-31

TPG

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT07013435 2026-03-30

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

Phase NA Not yet recruiting

Lymphoma

NCT05969821 2026-03-23

CHIS

Not yet recruiting

LymphoidMyeloidOther hematologic neoplasm

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT07483749 2026-03-19

HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors

Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07476378 2026-03-17

Archonc-001

Phase NA Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07297160 2026-03-04

CALySSEY

Phase 1 Not yet recruiting

GenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Kidney Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Phase 4 Not yet recruiting

DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT07412405 2026-02-17

ACITAC-001

Phase NA Not yet recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07383233 2026-02-03

CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma

Phase 1 Not yet recruiting

Lymphoma

NCT07352267 2026-01-20

Diagnostic Value and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy Versus Transbronchial Needle Aspiration in the Diagnosis of Lymphoma: a Randomized Controlled Trial

Phase NA Not yet recruiting

Lymphoma

NCT07335094 2026-01-12

A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma

NCT07316907 2026-01-05

A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Hematologic Neoplasms

NCT07289087 2025-12-17

QOL-ONE PRO-CT

Not yet recruiting

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

NCT07285174 2025-12-16

Shanghai Lymphoma Clinical Cohort

Not yet recruiting

Lymphoma

NCT07286539 2025-12-16

PEPOH

Phase NA Not yet recruiting

BreastGastrointestinalLymphoidOther hematologic neoplasmThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Lymphoma, Motor Activity, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT07259941 2025-12-02

PET-CT in Lymphoma Among the Eldery

Not yet recruiting

Lymphoma

NCT07206264 2025-10-03

ADAPT-MCL

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, Mantle-Cell

NCT07198958 2025-09-30

MITOX

Not yet recruiting

BreastGastrointestinalLymphoidPlasma cell

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms

NCT07131449 2025-08-20

succinylation

Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT07020260 2025-06-13

PACMAN

Phase 1/2 Not yet recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma

NCT07008872 2025-06-06

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Phase NA Not yet recruiting

Lymphoma

NCT06788600 2025-04-02

WGc-043

Not yet recruiting

Lymphoma, Recurrence

NCT06867536 2025-03-18

GLOHRT-01

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT06827639 2025-02-14

FUTURE

Not yet recruiting

BreastGastrointestinalGenitourinaryHead & NeckLymphoidOther hematologic neoplasmThoracic

Breast Neoplasms, Head and Neck Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Stomach Neoplasms, Urologic Neoplasms

NCT06817759 2025-02-10

Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer

Phase NA Not yet recruiting

LymphoidOther hematologic neoplasmPlasma cell

Anxiety Disorders, Lymphoma, Multiple Myeloma, Neoplasms, Pain, Hematologic Neoplasms

NCT06471296 2025-01-15

VIRONMENT

Not yet recruiting

Lymphoma, Virus Diseases

NCT06557330 2025-01-06

MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma

Phase 2 Not yet recruiting

Lymphoma

NCT06737835 2024-12-17

Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma

Not yet recruiting

Lymphoma

NCT06647329 2024-10-17

CAR-T Therapy

Phase 1 Not yet recruiting

Lymphoma, Recurrence

NCT06549335 2024-10-15

Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, Follicular

NCT06573099 2024-08-27

A Real-World Study on Extranodal Lymphoma

Not yet recruiting

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06573151 2024-08-27

Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

Phase 2 Not yet recruiting

Lymphoma

NCT06573645 2024-08-27

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

Phase 3 Not yet recruiting

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT03969693 2023-04-18

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

Not yet recruiting

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Cardiotoxicity

NCT05775705 2023-03-20

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

Phase 3 Not yet recruiting

LymphoidMyeloid

Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

NCT05681403 2023-01-12

Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma

Phase NA Not yet recruiting

Lymphoma

NCT05616325 2022-11-15

FERTILymph

Not yet recruiting

Lymphoma, Lymphoma, Follicular

NCT05391490 2022-05-26

KCAT19

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms